Vicarious Surgical Inc. 8-K

What Happened
Vicarious Surgical Inc. announced that at its special meeting of stockholders on January 9, 2026, shareholders approved the exercise of warrants issued on October 7, 2025 that allow purchase of up to 2,300,000 shares of Class A common stock. The vote was held with a quorum: 2,591,229 shares of Class A and Class B common stock were present or represented by proxy, representing approximately 78.18% of the outstanding total voting power. Holders of Class A had one vote per share and Class B had 20 votes per share; the record date was December 10, 2025. Reported vote totals (by voting power) were: For 14,991,093; Against 23,052; Abstentions 2,894.

Key Details

• Approved proposal: exercise of warrants issued Oct 7, 2025 to purchase up to 2,300,000 Class A shares.
• Meeting date and filing: Special Meeting on January 9, 2026; 8-K filed Jan 9, 2026; proxy describing the proposal filed Dec 16, 2025.
• Quorum: 2,591,229 shares present/represented, ~78.18% of voting power.
• Vote outcome: overwhelmingly approved — For: 14,991,093; Against: 23,052; Abstentions: 2,894 (voting power basis).

Why It Matters
Approval enables the warrants to be exercised per their terms, which could increase the company’s outstanding Class A shares and potentially raise capital if warrant holders exercise and pay the exercise price. That increase in shares would dilute existing ownership and could affect voting power and per-share metrics; investors should watch for subsequent disclosures about exercise prices, timing, and any resulting changes to shares outstanding or proceeds received.